JARDIANCE 90/10MG 10

About

Jardiance (Empagliflozin) 10 mg is a highly effective sodium-glucose co-transporter 2 (SGLT2) inhibitor prescribed for adults with type 2 diabetes to achieve better glycemic control. It functions by inhibiting the SGLT2 protein in the kidneys, which is responsible for reabsorbing glucose back into the bloodstream. By blocking this action, empagliflozin promotes the excretion of excess glucose in the urine, thereby lowering blood glucose levels. This medication offers substantial benefits beyond just glucose lowering; it has been proven to significantly reduce the risk of cardiovascular death, hospitalization for heart failure, and the progression of kidney disease in patients with type 2 diabetes and established cardiovascular disease or chronic kidney disease. Its comprehensive protective effects make it a valuable treatment option.

Uses

• Management of type 2 diabetes mellitus.
• To reduce the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease.
• To reduce the risk of hospitalization for heart failure in adults with type 2 diabetes.
• To reduce the risk of cardiovascular death and hospitalization for heart failure in adults with heart failure.

Directions For Use

Take orally once daily in the morning, with or without food, as directed by your doctor.

Benefits

• Effective blood glucose reduction.
• Lowered HbA1c levels.
• Promotes modest weight loss.
• Reduces risk of cardiovascular events.
• Slows progression of kidney disease.
• Low risk of hypoglycemia as monotherapy.

Side Effects

• Urinary tract infections
• Genital yeast infections
• Increased urination
• Thirst
• Nausea
• Constipation
• Dizziness
• Hypotension (especially at initiation)
• Ketoacidosis (rare)
• Fatigue
• Flu-like symptoms
• Joint pain

Safety Measures

• Alcohol - Moderate alcohol consumption is generally acceptable, but excessive intake may increase the risk of dehydration or ketoacidosis.
• Pregnancy - Not recommended during pregnancy, especially in the second and third trimesters. Consult your doctor.
• Breastfeeding - Not recommended during breastfeeding as it may pass into breast milk. Consult your doctor.
• Liver - Generally safe, but use with caution in severe hepatic impairment as data are limited.
• Kidney - Contraindicated in severe renal impairment or end-stage renal disease. Dose adjustment may be needed based on eGFR.
• Lung - Generally safe, no specific contraindications related to lung conditions.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.